Novel motif:75: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 14:55, 9 September 2013
name: | motif75_AGCCGAGCGCT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0051645 | Golgi localization | 4.602685e-9 |
GO:0001823 | mesonephros development | 1.639116e-8 |
GO:0021546 | rhombomere development | 2.353106e-8 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 2.820718e-8 |
GO:0021903 | rostrocaudal neural tube patterning | 3.243012e-8 |
GO:0007020 | microtubule nucleation | 1.086945e-7 |
GO:0021569 | rhombomere 3 development | 1.395500e-7 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 3.078198e-7 |
GO:0003310 | pancreatic A cell differentiation | 3.450924e-7 |
GO:0072176 | nephric duct development | 4.030694e-7 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 4.272392e-7 |
GO:0048752 | semicircular canal morphogenesis | 4.362855e-7 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 4.499304e-7 |
GO:0097152 | mesenchymal cell apoptosis | 4.499304e-7 |
GO:0060982 | coronary artery morphogenesis | 4.499304e-7 |
GO:0001830 | trophectodermal cell fate commitment | 4.499304e-7 |
GO:0072178 | nephric duct morphogenesis | 6.136039e-7 |
GO:0042473 | outer ear morphogenesis | 8.140596e-7 |
GO:0016570 | histone modification | 9.070684e-7 |
GO:0006353 | transcription termination, DNA-dependent | 9.908761e-7 |
GO:0003406 | retinal pigment epithelium development | 1.758075e-6 |
GO:0060023 | soft palate development | 2.376330e-6 |
GO:0021612 | facial nerve structural organization | 2.571636e-6 |
GO:0006473 | protein acetylation | 4.140526e-6 |
GO:0048561 | establishment of organ orientation | 4.581699e-6 |
GO:0016569 | covalent chromatin modification | 4.895032e-6 |
GO:0031468 | nuclear envelope reassembly | 5.139698e-6 |
GO:0061360 | optic chiasma development | 5.668198e-6 |
GO:2000597 | positive regulation of optic nerve formation | 5.668198e-6 |
GO:0021650 | vestibulocochlear nerve formation | 5.668198e-6 |
GO:0035799 | ureter maturation | 5.668198e-6 |
GO:0021633 | optic nerve structural organization | 5.668198e-6 |
GO:0035305 | negative regulation of dephosphorylation | 6.824366e-6 |
GO:0048486 | parasympathetic nervous system development | 8.937406e-6 |
GO:0043543 | protein acylation | 8.956224e-6 |
GO:0035308 | negative regulation of protein dephosphorylation | 9.392298e-6 |
GO:0021570 | rhombomere 4 development | 1.185942e-5 |
GO:0048702 | embryonic neurocranium morphogenesis | 1.373187e-5 |
GO:0021783 | preganglionic parasympathetic nervous system development | 1.539726e-5 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 1.688108e-5 |
GO:0035304 | regulation of protein dephosphorylation | 1.750442e-5 |
GO:0006475 | internal protein amino acid acetylation | 1.754480e-5 |
GO:0003329 | pancreatic PP cell fate commitment | 1.933456e-5 |
GO:0003326 | pancreatic A cell fate commitment | 1.933456e-5 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 1.978385e-5 |
GO:0072268 | pattern specification involved in metanephros development | 2.023748e-5 |
GO:0035229 | positive regulation of glutamate-cysteine ligase activity | 2.386346e-5 |
GO:0061032 | visceral serous pericardium development | 3.282669e-5 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 3.282669e-5 |
GO:0060580 | ventral spinal cord interneuron fate determination | 3.282669e-5 |
GO:0003327 | type B pancreatic cell fate commitment | 3.282669e-5 |
GO:0015809 | arginine transport | 3.365620e-5 |
GO:0070934 | CRD-mediated mRNA stabilization | 5.038852e-5 |
GO:0048665 | neuron fate specification | 5.303835e-5 |
GO:0032581 | ER-dependent peroxisome organization | 6.057856e-5 |
GO:0048663 | neuron fate commitment | 6.283232e-5 |
GO:0006386 | termination of RNA polymerase III transcription | 6.936562e-5 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 6.936562e-5 |
GO:0072162 | metanephric mesenchymal cell differentiation | 7.938976e-5 |
GO:0072179 | nephric duct formation | 8.452981e-5 |
GO:2000077 | negative regulation of type B pancreatic cell development | 8.806752e-5 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 9.310849e-5 |
GO:0051488 | activation of anaphase-promoting complex activity | 1.081098e-4 |
GO:0007288 | sperm axoneme assembly | 1.081098e-4 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 1.086375e-4 |
GO:0016577 | histone demethylation | 1.095022e-4 |
GO:0006534 | cysteine metabolic process | 1.140889e-4 |
GO:0072075 | metanephric mesenchyme development | 1.146924e-4 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 1.155427e-4 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 1.180885e-4 |
GO:0021561 | facial nerve development | 1.229319e-4 |
GO:0030917 | midbrain-hindbrain boundary development | 1.262747e-4 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.410106e-4 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.410106e-4 |
GO:0043973 | histone H3-K4 acetylation | 1.410106e-4 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 1.458399e-4 |
GO:0021568 | rhombomere 2 development | 1.504335e-4 |
GO:0031081 | nuclear pore distribution | 1.571938e-4 |
GO:0090102 | cochlea development | 1.618373e-4 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 1.633959e-4 |
GO:0043967 | histone H4 acetylation | 1.677662e-4 |
GO:0000414 | regulation of histone H3-K36 methylation | 1.781127e-4 |
GO:0009798 | axis specification | 1.930547e-4 |
GO:0032417 | positive regulation of sodium:hydrogen antiporter activity | 2.021701e-4 |
GO:0061303 | cornea development in camera-type eye | 2.030524e-4 |
GO:0033342 | negative regulation of collagen binding | 2.149490e-4 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 2.154786e-4 |
GO:0072166 | posterior mesonephric tubule development | 2.154786e-4 |
GO:0034198 | cellular response to amino acid starvation | 2.154786e-4 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 2.197242e-4 |
GO:0034401 | regulation of transcription by chromatin organization | 2.320387e-4 |
GO:0043267 | negative regulation of potassium ion transport | 2.326739e-4 |
GO:0071423 | malate transmembrane transport | 2.327496e-4 |
GO:0090324 | negative regulation of oxidative phosphorylation | 2.327496e-4 |
GO:0010255 | glucose mediated signaling pathway | 2.327496e-4 |
GO:0015709 | thiosulfate transport | 2.327496e-4 |
GO:0006844 | acyl carnitine transport | 2.327496e-4 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 2.405547e-4 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 2.419640e-4 |
GO:0042472 | inner ear morphogenesis | 2.460934e-4 |
GO:0042696 | menarche | 2.663484e-4 |
GO:0014807 | regulation of somitogenesis | 2.663484e-4 |
GO:0070874 | negative regulation of glycogen metabolic process | 2.855429e-4 |
GO:0021603 | cranial nerve formation | 2.855429e-4 |
GO:0031296 | B cell costimulation | 2.886976e-4 |
GO:0071539 | protein localization to centrosome | 2.903762e-4 |
GO:0021562 | vestibulocochlear nerve development | 3.089440e-4 |
GO:0045819 | positive regulation of glycogen catabolic process | 3.310736e-4 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 3.344363e-4 |
GO:0006482 | protein demethylation | 3.445557e-4 |
GO:0021877 | forebrain neuron fate commitment | 3.572053e-4 |
GO:0072177 | mesonephric duct development | 3.573338e-4 |
GO:0018393 | internal peptidyl-lysine acetylation | 3.771433e-4 |
GO:0018394 | peptidyl-lysine acetylation | 3.771638e-4 |
GO:0022027 | interkinetic nuclear migration | 3.777796e-4 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 3.829876e-4 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 3.865822e-4 |
GO:0045007 | depurination | 4.123697e-4 |
GO:0021610 | facial nerve morphogenesis | 4.174658e-4 |
GO:0060872 | semicircular canal development | 4.285099e-4 |
GO:0048013 | ephrin receptor signaling pathway | 4.490423e-4 |
GO:0015680 | intracellular copper ion transport | 4.572779e-4 |
GO:0015789 | UDP-N-acetylgalactosamine transport | 4.572779e-4 |
GO:0021837 | motogenic signaling involved in postnatal olfactory bulb interneuron migration | 4.572779e-4 |
GO:0015787 | UDP-glucuronic acid transport | 4.572779e-4 |
GO:0048548 | regulation of pinocytosis | 4.616057e-4 |
GO:0019367 | fatty acid elongation, saturated fatty acid | 4.651143e-4 |
GO:0046796 | viral genome transport in host cell | 4.727903e-4 |
GO:0021796 | cerebral cortex regionalization | 4.727903e-4 |
GO:0032864 | activation of Cdc42 GTPase activity | 4.777151e-4 |
GO:0060689 | cell differentiation involved in salivary gland development | 4.778615e-4 |
GO:0007549 | dosage compensation | 4.937502e-4 |
GO:0006285 | base-excision repair, AP site formation | 4.937502e-4 |
GO:0035306 | positive regulation of dephosphorylation | 5.302308e-4 |
GO:0048255 | mRNA stabilization | 5.428145e-4 |
GO:0016573 | histone acetylation | 5.447362e-4 |
GO:0071279 | cellular response to cobalt ion | 5.537527e-4 |
GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific | 5.537527e-4 |
GO:0010637 | negative regulation of mitochondrial fusion | 5.537527e-4 |
GO:0031119 | tRNA pseudouridine synthesis | 5.537527e-4 |
GO:0048102 | autophagic cell death | 5.708561e-4 |
GO:0010458 | exit from mitosis | 5.708561e-4 |
GO:0035329 | hippo signaling cascade | 5.833665e-4 |
GO:0006298 | mismatch repair | 5.833665e-4 |
GO:0008272 | sulfate transport | 5.930176e-4 |
GO:0043923 | positive regulation by host of viral transcription | 5.947374e-4 |
GO:0090241 | negative regulation of histone H4 acetylation | 5.951428e-4 |
GO:0043966 | histone H3 acetylation | 6.014315e-4 |
GO:0009952 | anterior/posterior pattern specification | 6.135733e-4 |
GO:0032312 | regulation of ARF GTPase activity | 6.185210e-4 |
GO:0021523 | somatic motor neuron differentiation | 6.590308e-4 |
GO:0072300 | positive regulation of metanephric glomerulus development | 6.616176e-4 |
GO:0035665 | TIRAP-dependent toll-like receptor 4 signaling pathway | 6.766784e-4 |
GO:2000340 | positive regulation of chemokine (C-X-C motif) ligand 1 production | 6.766784e-4 |
GO:0032738 | positive regulation of interleukin-15 production | 6.766784e-4 |
GO:0021759 | globus pallidus development | 6.806772e-4 |
GO:0071110 | histone biotinylation | 7.011185e-4 |
GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 7.011185e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 7.011185e-4 |
GO:0048210 | Golgi vesicle fusion to target membrane | 7.028390e-4 |
GO:0035307 | positive regulation of protein dephosphorylation | 7.088445e-4 |
GO:0015879 | carnitine transport | 7.088445e-4 |
GO:0010225 | response to UV-C | 7.523892e-4 |
GO:0008298 | intracellular mRNA localization | 7.586955e-4 |
GO:0070988 | demethylation | 8.570633e-4 |
GO:0009301 | snRNA transcription | 8.661029e-4 |
GO:0070179 | D-serine biosynthetic process | 8.812619e-4 |
GO:0051793 | medium-chain fatty acid catabolic process | 8.812619e-4 |
GO:0033260 | DNA replication involved in S phase | 8.812619e-4 |
GO:0042946 | glucoside transport | 8.812619e-4 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 8.886503e-4 |
GO:0003002 | regionalization | 9.045391e-4 |
GO:0035566 | regulation of metanephros size | 9.167107e-4 |
GO:0045719 | negative regulation of glycogen biosynthetic process | 9.348095e-4 |
GO:0034447 | very-low-density lipoprotein particle clearance | 9.395123e-4 |
GO:0072133 | metanephric mesenchyme morphogenesis | 9.473783e-4 |
GO:0022007 | convergent extension involved in neural plate elongation | 9.492539e-4 |
GO:0060923 | cardiac muscle cell fate commitment | 9.700227e-4 |
GO:0021986 | habenula development | 1.049696e-3 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 1.127158e-3 |
GO:0007614 | short-term memory | 1.140366e-3 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 1.230020e-3 |
GO:0060061 | Spemann organizer formation | 1.250597e-3 |
GO:0060177 | regulation of angiotensin metabolic process | 1.278640e-3 |
GO:0008033 | tRNA processing | 1.286206e-3 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 1.293530e-3 |
GO:0021571 | rhombomere 5 development | 1.293530e-3 |
GO:0006853 | carnitine shuttle | 1.317809e-3 |
GO:0021918 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment | 1.320800e-3 |
GO:0021905 | forebrain-midbrain boundary formation | 1.320800e-3 |
GO:0003322 | pancreatic A cell development | 1.320800e-3 |
GO:0006419 | alanyl-tRNA aminoacylation | 1.320800e-3 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 1.320800e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 1.355002e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 1.361500e-3 |
GO:0021895 | cerebral cortex neuron differentiation | 1.367142e-3 |
GO:0005981 | regulation of glycogen catabolic process | 1.391301e-3 |
GO:0021520 | spinal cord motor neuron cell fate specification | 1.393120e-3 |
GO:0016925 | protein sumoylation | 1.448092e-3 |
GO:0015802 | basic amino acid transport | 1.454707e-3 |
GO:0035284 | brain segmentation | 1.458687e-3 |
GO:0071422 | succinate transmembrane transport | 1.461060e-3 |
GO:0070194 | synaptonemal complex disassembly | 1.461060e-3 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 1.461060e-3 |
GO:0045908 | negative regulation of vasodilation | 1.461060e-3 |
GO:0046015 | regulation of transcription by glucose | 1.465977e-3 |
GO:0006363 | termination of RNA polymerase I transcription | 1.508304e-3 |
GO:0060430 | lung saccule development | 1.524825e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 1.524825e-3 |
GO:0042421 | norepinephrine biosynthetic process | 1.585415e-3 |
GO:0021604 | cranial nerve structural organization | 1.661928e-3 |
GO:0010994 | free ubiquitin chain polymerization | 1.662862e-3 |
GO:0006420 | arginyl-tRNA aminoacylation | 1.662862e-3 |
GO:0046950 | cellular ketone body metabolic process | 1.667453e-3 |
GO:0000088 | mitotic prophase | 1.673458e-3 |
GO:0022601 | menstrual cycle phase | 1.760897e-3 |
GO:0042255 | ribosome assembly | 1.760897e-3 |
GO:0090103 | cochlea morphogenesis | 1.766669e-3 |
GO:0006083 | acetate metabolic process | 1.809183e-3 |
GO:0072086 | specification of loop of Henle identity | 1.837076e-3 |
GO:0060179 | male mating behavior | 1.906036e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.906036e-3 |
GO:0060242 | contact inhibition | 1.943069e-3 |
GO:0046952 | ketone body catabolic process | 1.943069e-3 |
GO:0060253 | negative regulation of glial cell proliferation | 2.030691e-3 |
GO:0006438 | valyl-tRNA aminoacylation | 2.111542e-3 |
GO:0043983 | histone H4-K12 acetylation | 2.124332e-3 |
GO:0002523 | leukocyte migration involved in inflammatory response | 2.130688e-3 |
GO:0002002 | regulation of angiotensin levels in blood | 2.210187e-3 |
GO:0045200 | establishment of neuroblast polarity | 2.223200e-3 |
GO:0002082 | regulation of oxidative phosphorylation | 2.223200e-3 |
GO:0030902 | hindbrain development | 2.317580e-3 |
GO:0048103 | somatic stem cell division | 2.366393e-3 |
GO:0048149 | behavioral response to ethanol | 2.399357e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 2.399361e-3 |
GO:0060033 | anatomical structure regression | 2.406935e-3 |
GO:0072081 | specification of nephron tubule identity | 2.441283e-3 |
GO:0046940 | nucleoside monophosphate phosphorylation | 2.441431e-3 |
GO:0060465 | pharynx development | 2.441431e-3 |
GO:0042942 | D-serine transport | 2.441431e-3 |
GO:0002897 | positive regulation of central B cell tolerance induction | 2.441431e-3 |
GO:0002508 | central tolerance induction | 2.441431e-3 |
GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process | 2.587721e-3 |
GO:0072164 | mesonephric tubule development | 2.590942e-3 |
GO:0021930 | cerebellar granule cell precursor proliferation | 2.622886e-3 |
GO:0032790 | ribosome disassembly | 2.755507e-3 |
GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 2.777201e-3 |
GO:0046684 | response to pyrethroid | 2.815872e-3 |
GO:0006430 | lysyl-tRNA aminoacylation | 2.826799e-3 |
GO:0021658 | rhombomere 3 morphogenesis | 2.839998e-3 |
GO:0021754 | facial nucleus development | 2.839998e-3 |
GO:0080164 | regulation of nitric oxide metabolic process | 2.912872e-3 |
GO:0022400 | regulation of rhodopsin mediated signaling pathway | 2.912872e-3 |
GO:0016058 | maintenance of membrane potential in photoreceptor cell by rhodopsin mediated signaling | 2.912872e-3 |
GO:0018026 | peptidyl-lysine monomethylation | 2.993335e-3 |
GO:0035414 | negative regulation of catenin import into nucleus | 3.032549e-3 |
GO:0030488 | tRNA methylation | 3.057027e-3 |
GO:0016140 | O-glycoside metabolic process | 3.057027e-3 |
GO:0006538 | glutamate catabolic process | 3.118786e-3 |
GO:0045955 | negative regulation of calcium ion-dependent exocytosis | 3.118786e-3 |
GO:0042471 | ear morphogenesis | 3.206370e-3 |
GO:0019542 | propionate biosynthetic process | 3.274102e-3 |
GO:0019413 | acetate biosynthetic process | 3.274102e-3 |
GO:0016571 | histone methylation | 3.277652e-3 |
GO:0048378 | regulation of lateral mesodermal cell fate specification | 3.305705e-3 |
GO:0033326 | cerebrospinal fluid secretion | 3.305705e-3 |
GO:0002693 | positive regulation of cellular extravasation | 3.305705e-3 |
GO:0043508 | negative regulation of JUN kinase activity | 3.457941e-3 |
GO:0031627 | telomeric loop formation | 3.464985e-3 |
GO:0031848 | protection from non-homologous end joining at telomere | 3.583004e-3 |
GO:0060022 | hard palate development | 3.588667e-3 |
GO:0071109 | superior temporal gyrus development | 3.794076e-3 |
GO:0001826 | inner cell mass cell differentiation | 3.794076e-3 |
GO:0072298 | regulation of metanephric glomerulus development | 3.799581e-3 |
GO:0070286 | axonemal dynein complex assembly | 3.811959e-3 |
GO:0070947 | neutrophil mediated killing of fungus | 3.811959e-3 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 3.848612e-3 |
GO:0072107 | positive regulation of ureteric bud formation | 3.864507e-3 |
GO:0035090 | maintenance of apical/basal cell polarity | 3.923224e-3 |
GO:0034770 | histone H4-K20 methylation | 3.991645e-3 |
GO:0006369 | termination of RNA polymerase II transcription | 4.035451e-3 |
GO:0009264 | deoxyribonucleotide catabolic process | 4.060432e-3 |
GO:0030433 | ER-associated protein catabolic process | 4.069258e-3 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 4.072303e-3 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 4.072303e-3 |
GO:0060112 | generation of ovulation cycle rhythm | 4.075978e-3 |
GO:0048549 | positive regulation of pinocytosis | 4.075978e-3 |
GO:0017145 | stem cell division | 4.103128e-3 |
GO:0060976 | coronary vasculature development | 4.201962e-3 |
GO:0072171 | mesonephric tubule morphogenesis | 4.231028e-3 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 4.353871e-3 |
GO:0043418 | homocysteine catabolic process | 4.434306e-3 |
GO:0019346 | transsulfuration | 4.434306e-3 |
GO:0019343 | cysteine biosynthetic process via cystathionine | 4.434306e-3 |
GO:0006535 | cysteine biosynthetic process from serine | 4.434306e-3 |
GO:0040040 | thermosensory behavior | 4.576082e-3 |
GO:0006177 | GMP biosynthetic process | 4.610772e-3 |
GO:0010506 | regulation of autophagy | 4.631517e-3 |
GO:0021532 | neural tube patterning | 4.666431e-3 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 4.707188e-3 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 4.764380e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 4.872761e-3 |
GO:0007379 | segment specification | 4.874791e-3 |
GO:0060286 | flagellar cell motility | 4.886844e-3 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 4.955925e-3 |
GO:0046078 | dUMP metabolic process | 5.118504e-3 |
GO:0071335 | hair follicle cell proliferation | 5.118504e-3 |
GO:0032290 | peripheral nervous system myelin formation | 5.118504e-3 |
GO:0021644 | vagus nerve morphogenesis | 5.126801e-3 |
GO:0035511 | oxidative DNA demethylation | 5.364758e-3 |
GO:0001560 | regulation of cell growth by extracellular stimulus | 5.364758e-3 |
GO:0003180 | aortic valve morphogenesis | 5.388744e-3 |
GO:0009637 | response to blue light | 5.575847e-3 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 5.605911e-3 |
GO:0006551 | leucine metabolic process | 5.645861e-3 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 5.745870e-3 |
GO:0019086 | late viral mRNA transcription | 5.745870e-3 |
GO:0043088 | regulation of Cdc42 GTPase activity | 5.770491e-3 |
GO:0072180 | mesonephric duct morphogenesis | 5.788127e-3 |
GO:0018277 | protein deamination | 5.795740e-3 |
GO:0030423 | targeting of mRNA for destruction involved in RNA interference | 5.883112e-3 |
GO:0002003 | angiotensin maturation | 5.883112e-3 |
GO:0010587 | miRNA catabolic process | 5.883112e-3 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 6.021858e-3 |
GO:0034214 | protein hexamerization | 6.030394e-3 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 6.030394e-3 |
GO:0002011 | morphogenesis of an epithelial sheet | 6.255066e-3 |
GO:0048305 | immunoglobulin secretion | 6.433372e-3 |
GO:0070781 | response to biotin | 6.444939e-3 |
GO:0010633 | negative regulation of epithelial cell migration | 6.599746e-3 |
GO:0006474 | N-terminal protein amino acid acetylation | 6.599746e-3 |
GO:0043266 | regulation of potassium ion transport | 6.641734e-3 |
GO:2000974 | negative regulation of pro-B cell differentiation | 6.684332e-3 |
GO:0042538 | hyperosmotic salinity response | 6.691110e-3 |
GO:0070407 | oxidation-dependent protein catabolic process | 6.809700e-3 |
GO:0072537 | fibroblast activation | 6.809700e-3 |
GO:0006272 | leading strand elongation | 6.809700e-3 |
GO:0097039 | protein linear polyubiquitination | 6.818950e-3 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 6.818950e-3 |
GO:0090239 | regulation of histone H4 acetylation | 7.000988e-3 |
GO:0070166 | enamel mineralization | 7.000988e-3 |
GO:0018022 | peptidyl-lysine methylation | 7.143434e-3 |
GO:0016574 | histone ubiquitination | 7.156184e-3 |
GO:0010991 | negative regulation of SMAD protein complex assembly | 7.209248e-3 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 7.617193e-3 |
GO:0070574 | cadmium ion transmembrane transport | 7.617193e-3 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 7.687183e-3 |
GO:0048532 | anatomical structure arrangement | 7.690445e-3 |
GO:0035607 | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 7.788258e-3 |
GO:0006398 | histone mRNA 3'-end processing | 7.788258e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 7.788258e-3 |
GO:0090192 | regulation of glomerulus development | 7.826474e-3 |
GO:0060977 | coronary vasculature morphogenesis | 7.858446e-3 |
GO:0001880 | Mullerian duct regression | 7.858446e-3 |
GO:0048733 | sebaceous gland development | 7.925274e-3 |
GO:0061088 | regulation of sequestering of zinc ion | 7.971227e-3 |
GO:0060267 | positive regulation of respiratory burst | 7.971227e-3 |
GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter | 8.125466e-3 |
GO:0008355 | olfactory learning | 8.125466e-3 |
GO:0042149 | cellular response to glucose starvation | 8.283201e-3 |
GO:0065001 | specification of axis polarity | 8.285629e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 8.285629e-3 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 8.333330e-3 |
GO:0010923 | negative regulation of phosphatase activity | 8.396946e-3 |
GO:0046724 | oxalic acid secretion | 8.424291e-3 |
GO:0048242 | epinephrine secretion | 8.424291e-3 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 8.424291e-3 |
GO:0021993 | initiation of neural tube closure | 8.437780e-3 |
GO:0015734 | taurine transport | 8.515329e-3 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 8.538862e-3 |
GO:0007089 | traversing start control point of mitotic cell cycle | 8.559091e-3 |
GO:0006536 | glutamate metabolic process | 8.633053e-3 |
GO:0042415 | norepinephrine metabolic process | 8.704948e-3 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 9.010039e-3 |
GO:0021778 | oligodendrocyte cell fate specification | 9.165939e-3 |
GO:0048560 | establishment of anatomical structure orientation | 9.200391e-3 |
GO:0042450 | arginine biosynthetic process via ornithine | 9.256201e-3 |
GO:0042418 | epinephrine biosynthetic process | 9.256201e-3 |
GO:0042780 | tRNA 3'-end processing | 9.256201e-3 |
GO:0080009 | mRNA methylation | 9.256201e-3 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 9.256201e-3 |
GO:0006585 | dopamine biosynthetic process from tyrosine | 9.256201e-3 |
GO:0035852 | horizontal cell localization | 9.256201e-3 |
GO:0035849 | nephric duct elongation | 9.256201e-3 |
GO:0008049 | male courtship behavior | 9.256201e-3 |
GO:0035502 | metanephric ureteric bud development | 9.256201e-3 |
GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 9.256201e-3 |
GO:0035847 | uterine epithelium development | 9.256201e-3 |
GO:0035846 | oviduct epithelium development | 9.256201e-3 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 9.333541e-3 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 9.338775e-3 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 9.385585e-3 |
GO:0010477 | response to sulfur dioxide | 9.385585e-3 |
GO:0002457 | T cell antigen processing and presentation | 9.385585e-3 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 9.456789e-3 |
GO:0003148 | outflow tract septum morphogenesis | 9.469294e-3 |
GO:0015864 | pyrimidine nucleoside transport | 9.531564e-3 |
GO:0010507 | negative regulation of autophagy | 9.534503e-3 |
GO:0042278 | purine nucleoside metabolic process | 9.662383e-3 |
GO:0007158 | neuron cell-cell adhesion | 9.732554e-3 |
GO:2000703 | negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation | 9.794198e-3 |
GO:2000734 | negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation | 9.794198e-3 |
GO:2000667 | positive regulation of interleukin-13 secretion | 9.794198e-3 |
GO:2000662 | regulation of interleukin-5 secretion | 9.794198e-3 |
GO:2000665 | regulation of interleukin-13 secretion | 9.794198e-3 |
GO:2000607 | negative regulation of cell proliferation involved in mesonephros development | 9.794198e-3 |
GO:2000664 | positive regulation of interleukin-5 secretion | 9.794198e-3 |
GO:0006901 | vesicle coating | 9.978149e-3 |
GO:2000737 | negative regulation of stem cell differentiation | 9.984876e-3 |
GO:0034261 | negative regulation of Ras GTPase activity | 9.984876e-3 |
GO:0061101 | neuroendocrine cell differentiation | 1.012910e-2 |
GO:0032606 | type I interferon production | 1.031701e-2 |
GO:0006287 | base-excision repair, gap-filling | 1.071387e-2 |
GO:0060708 | spongiotrophoblast differentiation | 1.084073e-2 |
GO:0048483 | autonomic nervous system development | 1.100304e-2 |
GO:0034766 | negative regulation of ion transmembrane transport | 1.102038e-2 |
GO:0061144 | alveolar secondary septum development | 1.102038e-2 |
GO:0031365 | N-terminal protein amino acid modification | 1.113353e-2 |
GO:0016241 | regulation of macroautophagy | 1.126485e-2 |
GO:0006244 | pyrimidine nucleotide catabolic process | 1.135213e-2 |
GO:0016233 | telomere capping | 1.144873e-2 |
GO:0060816 | random inactivation of X chromosome | 1.185765e-2 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 1.185765e-2 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 1.185765e-2 |
GO:0048562 | embryonic organ morphogenesis | 1.211207e-2 |
GO:0035873 | lactate transmembrane transport | 1.213428e-2 |
GO:0048050 | post-embryonic eye morphogenesis | 1.235194e-2 |
GO:0035721 | intraflagellar retrograde transport | 1.235194e-2 |
GO:0042474 | middle ear morphogenesis | 1.238458e-2 |
GO:0031643 | positive regulation of myelination | 1.241160e-2 |
GO:0060017 | parathyroid gland development | 1.242826e-2 |
GO:0002636 | positive regulation of germinal center formation | 1.252659e-2 |
GO:0090104 | pancreatic E cell differentiation | 1.253871e-2 |
GO:0034509 | centromeric core chromatin assembly | 1.253871e-2 |
GO:0003311 | pancreatic D cell differentiation | 1.253871e-2 |
GO:0030393 | fructoselysine metabolic process | 1.253871e-2 |
GO:0034260 | negative regulation of GTPase activity | 1.289292e-2 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 1.289292e-2 |
GO:0019087 | transformation of host cell by virus | 1.339414e-2 |
GO:0048268 | clathrin coat assembly | 1.359564e-2 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 1.368945e-2 |
GO:0021588 | cerebellum formation | 1.368945e-2 |
GO:2000002 | negative regulation of DNA damage checkpoint | 1.368945e-2 |
GO:0021551 | central nervous system morphogenesis | 1.368945e-2 |
GO:0002175 | protein localization to paranode region of axon | 1.368945e-2 |
GO:0010452 | histone H3-K36 methylation | 1.369485e-2 |
GO:0050434 | positive regulation of viral transcription | 1.379173e-2 |
GO:0001522 | pseudouridine synthesis | 1.414104e-2 |
GO:0030422 | production of siRNA involved in RNA interference | 1.421707e-2 |
GO:0031122 | cytoplasmic microtubule organization | 1.425602e-2 |
GO:0016576 | histone dephosphorylation | 1.458953e-2 |
GO:0000578 | embryonic axis specification | 1.466089e-2 |
GO:0014707 | branchiomeric skeletal muscle development | 1.472895e-2 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 1.481505e-2 |
GO:0018342 | protein prenylation | 1.481505e-2 |
GO:0035095 | behavioral response to nicotine | 1.500314e-2 |
GO:0045351 | type I interferon biosynthetic process | 1.500643e-2 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 1.561231e-2 |
GO:0002691 | regulation of cellular extravasation | 1.599374e-2 |
GO:0034063 | stress granule assembly | 1.600123e-2 |
GO:0021779 | oligodendrocyte cell fate commitment | 1.600123e-2 |
GO:0045199 | maintenance of epithelial cell apical/basal polarity | 1.601050e-2 |
GO:0034969 | histone arginine methylation | 1.628166e-2 |
GO:0001839 | neural plate morphogenesis | 1.628166e-2 |
GO:0090281 | negative regulation of calcium ion import | 1.629295e-2 |
GO:0071584 | negative regulation of zinc ion import | 1.629295e-2 |
GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process | 1.629295e-2 |
GO:0051791 | medium-chain fatty acid metabolic process | 1.629295e-2 |
GO:0032108 | negative regulation of response to nutrient levels | 1.630805e-2 |
GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 1.643050e-2 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 1.661843e-2 |
GO:0007386 | compartment pattern specification | 1.661843e-2 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 1.682265e-2 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 1.682265e-2 |
GO:0000115 | regulation of transcription involved in S phase of mitotic cell cycle | 1.682265e-2 |
GO:0001988 | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 1.682265e-2 |
GO:0051647 | nucleus localization | 1.698616e-2 |
GO:0001842 | neural fold formation | 1.720683e-2 |
GO:0033278 | cell proliferation in midbrain | 1.750323e-2 |
GO:0015842 | synaptic vesicle amine transport | 1.750323e-2 |
GO:0002536 | respiratory burst involved in inflammatory response | 1.760645e-2 |
GO:0033861 | negative regulation of NAD(P)H oxidase activity | 1.760645e-2 |
GO:0008295 | spermidine biosynthetic process | 1.760645e-2 |
GO:0006489 | dolichyl diphosphate biosynthetic process | 1.760645e-2 |
GO:0060972 | left/right pattern formation | 1.785511e-2 |
GO:0015728 | mevalonate transport | 1.796155e-2 |
GO:0071394 | cellular response to testosterone stimulus | 1.796155e-2 |
GO:0006313 | transposition, DNA-mediated | 1.796155e-2 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 1.802392e-2 |
GO:0035802 | adrenal cortex formation | 1.802392e-2 |
GO:0051660 | establishment of centrosome localization | 1.806292e-2 |
GO:0042335 | cuticle development | 1.806292e-2 |
GO:0021540 | corpus callosum morphogenesis | 1.806292e-2 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 1.806292e-2 |
GO:0051318 | G1 phase | 1.829461e-2 |
GO:0035137 | hindlimb morphogenesis | 1.900149e-2 |
GO:0034968 | histone lysine methylation | 1.922825e-2 |
GO:0021575 | hindbrain morphogenesis | 1.943256e-2 |
GO:0032933 | SREBP-mediated signaling pathway | 1.960972e-2 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 1.976543e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0015780 | nucleotide-sugar transport | 5.798993e-8 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 1.896004e-7 |
GO:0034498 | early endosome to Golgi transport | 7.956593e-7 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 8.355002e-7 |
GO:0010897 | negative regulation of triglyceride catabolic process | 8.355002e-7 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 1.162262e-6 |
GO:0003002 | regionalization | 1.752800e-6 |
GO:0035520 | monoubiquitinated protein deubiquitination | 2.609846e-6 |
GO:0031508 | centromeric heterochromatin formation | 2.609846e-6 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 2.853508e-6 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 2.853508e-6 |
GO:0016573 | histone acetylation | 2.881596e-6 |
GO:0048665 | neuron fate specification | 4.140602e-6 |
GO:0021520 | spinal cord motor neuron cell fate specification | 4.508648e-6 |
GO:0001824 | blastocyst development | 4.746904e-6 |
GO:0006351 | transcription, DNA-dependent | 5.996310e-6 |
GO:0031507 | heterochromatin formation | 6.104385e-6 |
GO:2000772 | regulation of cellular senescence | 6.496056e-6 |
GO:0032774 | RNA biosynthetic process | 7.059548e-6 |
GO:0018394 | peptidyl-lysine acetylation | 8.264849e-6 |
GO:0021877 | forebrain neuron fate commitment | 8.368183e-6 |
GO:0007389 | pattern specification process | 8.603278e-6 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 8.853955e-6 |
GO:0006657 | CDP-choline pathway | 8.853955e-6 |
GO:0010467 | gene expression | 1.073320e-5 |
GO:0050711 | negative regulation of interleukin-1 secretion | 1.225759e-5 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 1.302332e-5 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 1.302332e-5 |
GO:0018205 | peptidyl-lysine modification | 1.441001e-5 |
GO:0018393 | internal peptidyl-lysine acetylation | 1.611569e-5 |
GO:2000078 | positive regulation of type B pancreatic cell development | 1.626538e-5 |
GO:0021903 | rostrocaudal neural tube patterning | 2.347679e-5 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 2.384980e-5 |
GO:0060976 | coronary vasculature development | 2.544594e-5 |
GO:0043966 | histone H3 acetylation | 2.773486e-5 |
GO:0006438 | valyl-tRNA aminoacylation | 3.624695e-5 |
GO:0046605 | regulation of centrosome cycle | 3.710471e-5 |
GO:0090231 | regulation of spindle checkpoint | 4.504718e-5 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 4.740261e-5 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 4.870786e-5 |
GO:0006409 | tRNA export from nucleus | 4.870786e-5 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 5.098241e-5 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 5.641249e-5 |
GO:0046477 | glycosylceramide catabolic process | 6.562762e-5 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 6.562762e-5 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 7.186323e-5 |
GO:0006473 | protein acetylation | 7.257234e-5 |
GO:0034227 | tRNA thio-modification | 7.896427e-5 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 7.896427e-5 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 8.538763e-5 |
GO:0060977 | coronary vasculature morphogenesis | 8.926394e-5 |
GO:0072172 | mesonephric tubule formation | 9.319755e-5 |
GO:0021546 | rhombomere development | 9.843231e-5 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 9.882846e-5 |
GO:0006475 | internal protein amino acid acetylation | 1.032092e-4 |
GO:0001709 | cell fate determination | 1.260358e-4 |
GO:0016070 | RNA metabolic process | 1.305307e-4 |
GO:0007051 | spindle organization | 1.463359e-4 |
GO:0072164 | mesonephric tubule development | 1.542109e-4 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.617471e-4 |
GO:0021514 | ventral spinal cord interneuron differentiation | 1.717627e-4 |
GO:0016567 | protein ubiquitination | 1.879412e-4 |
GO:0071168 | protein localization to chromatin | 1.940799e-4 |
GO:0000414 | regulation of histone H3-K36 methylation | 1.961775e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 2.012294e-4 |
GO:0001826 | inner cell mass cell differentiation | 2.036278e-4 |
GO:0010312 | detoxification of zinc ion | 2.095353e-4 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 2.115420e-4 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 2.514076e-4 |
GO:0030878 | thyroid gland development | 2.519819e-4 |
GO:0001825 | blastocyst formation | 2.545648e-4 |
GO:0070831 | basement membrane assembly | 2.569080e-4 |
GO:2000384 | negative regulation of ectoderm development | 2.666662e-4 |
GO:0034382 | chylomicron remnant clearance | 2.670859e-4 |
GO:0072075 | metanephric mesenchyme development | 2.864146e-4 |
GO:0046931 | pore complex assembly | 2.871870e-4 |
GO:0051775 | response to redox state | 3.271094e-4 |
GO:0048539 | bone marrow development | 3.280793e-4 |
GO:2000774 | positive regulation of cellular senescence | 3.366356e-4 |
GO:0090402 | oncogene-induced senescence | 3.366356e-4 |
GO:0035986 | senescence-associated heterochromatin focus formation | 3.366356e-4 |
GO:0097084 | vascular smooth muscle cell development | 3.420772e-4 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 3.561294e-4 |
GO:0032312 | regulation of ARF GTPase activity | 3.611261e-4 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 3.639340e-4 |
GO:0061034 | olfactory bulb mitral cell layer development | 3.639340e-4 |
GO:0046599 | regulation of centriole replication | 3.943938e-4 |
GO:0000080 | G1 phase of mitotic cell cycle | 3.966266e-4 |
GO:0021568 | rhombomere 2 development | 4.001904e-4 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 4.112661e-4 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 4.132974e-4 |
GO:0090224 | regulation of spindle organization | 4.391924e-4 |
GO:0032446 | protein modification by small protein conjugation | 4.516481e-4 |
GO:0044342 | type B pancreatic cell proliferation | 4.633807e-4 |
GO:0016139 | glycoside catabolic process | 4.633807e-4 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 4.633807e-4 |
GO:0001830 | trophectodermal cell fate commitment | 4.633807e-4 |
GO:0019348 | dolichol metabolic process | 4.658775e-4 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 4.705469e-4 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 4.731263e-4 |
GO:0007059 | chromosome segregation | 4.931298e-4 |
GO:0051169 | nuclear transport | 5.375640e-4 |
GO:0006913 | nucleocytoplasmic transport | 5.708285e-4 |
GO:0008216 | spermidine metabolic process | 6.028293e-4 |
GO:0009817 | defense response to fungus, incompatible interaction | 6.028293e-4 |
GO:0021527 | spinal cord association neuron differentiation | 6.035102e-4 |
GO:0051252 | regulation of RNA metabolic process | 6.289835e-4 |
GO:0006355 | regulation of transcription, DNA-dependent | 6.327045e-4 |
GO:0061017 | hepatoblast differentiation | 6.399159e-4 |
GO:0060948 | cardiac vascular smooth muscle cell development | 6.399159e-4 |
GO:0061009 | common bile duct development | 6.489522e-4 |
GO:0061032 | visceral serous pericardium development | 6.545662e-4 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 6.562361e-4 |
GO:0090209 | negative regulation of triglyceride metabolic process | 6.865464e-4 |
GO:0048663 | neuron fate commitment | 7.085213e-4 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 7.095547e-4 |
GO:0032057 | negative regulation of translational initiation in response to stress | 7.673286e-4 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 7.673286e-4 |
GO:0009953 | dorsal/ventral pattern formation | 7.743602e-4 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 7.794901e-4 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 7.962375e-4 |
GO:0006656 | phosphatidylcholine biosynthetic process | 8.142770e-4 |
GO:0035195 | gene silencing by miRNA | 8.210568e-4 |
GO:0050983 | deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 8.313276e-4 |
GO:0048239 | negative regulation of DNA recombination at telomere | 8.313276e-4 |
GO:0051684 | maintenance of Golgi location | 8.313276e-4 |
GO:0006430 | lysyl-tRNA aminoacylation | 8.313276e-4 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 8.313276e-4 |
GO:0046452 | dihydrofolate metabolic process | 8.313276e-4 |
GO:0060214 | endocardium formation | 8.458778e-4 |
GO:0060318 | definitive erythrocyte differentiation | 8.836212e-4 |
GO:0031055 | chromatin remodeling at centromere | 8.954513e-4 |
GO:0048103 | somatic stem cell division | 9.098995e-4 |
GO:0060037 | pharyngeal system development | 9.121128e-4 |
GO:0045875 | negative regulation of sister chromatid cohesion | 9.306544e-4 |
GO:0072171 | mesonephric tubule morphogenesis | 9.550361e-4 |
GO:0022007 | convergent extension involved in neural plate elongation | 9.926449e-4 |
GO:0002098 | tRNA wobble uridine modification | 9.926449e-4 |
GO:0021513 | spinal cord dorsal/ventral patterning | 1.004377e-3 |
GO:0043543 | protein acylation | 1.025606e-3 |
GO:0042733 | embryonic digit morphogenesis | 1.068012e-3 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 1.089771e-3 |
GO:0032853 | positive regulation of Ran GTPase activity | 1.116359e-3 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 1.120969e-3 |
GO:0051225 | spindle assembly | 1.159041e-3 |
GO:0032007 | negative regulation of TOR signaling cascade | 1.163985e-3 |
GO:2000380 | regulation of mesoderm development | 1.166253e-3 |
GO:0042976 | activation of Janus kinase activity | 1.175079e-3 |
GO:2000142 | regulation of transcription initiation, DNA-dependent | 1.218826e-3 |
GO:0021511 | spinal cord patterning | 1.218826e-3 |
GO:0032488 | Cdc42 protein signal transduction | 1.220765e-3 |
GO:0060620 | regulation of cholesterol import | 1.225030e-3 |
GO:0006346 | methylation-dependent chromatin silencing | 1.225030e-3 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 1.245400e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.247799e-3 |
GO:2000383 | regulation of ectoderm development | 1.254914e-3 |
GO:0007212 | dopamine receptor signaling pathway | 1.319201e-3 |
GO:0060396 | growth hormone receptor signaling pathway | 1.438244e-3 |
GO:0006325 | chromatin organization | 1.480265e-3 |
GO:0006287 | base-excision repair, gap-filling | 1.577732e-3 |
GO:0021521 | ventral spinal cord interneuron specification | 1.610445e-3 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 1.668207e-3 |
GO:0060389 | pathway-restricted SMAD protein phosphorylation | 1.720933e-3 |
GO:0046580 | negative regulation of Ras protein signal transduction | 1.737536e-3 |
GO:0016226 | iron-sulfur cluster assembly | 1.779194e-3 |
GO:0090304 | nucleic acid metabolic process | 1.835533e-3 |
GO:0021872 | forebrain generation of neurons | 1.844697e-3 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 1.849815e-3 |
GO:0060850 | regulation of transcription involved in cell fate commitment | 1.904950e-3 |
GO:0035066 | positive regulation of histone acetylation | 1.989301e-3 |
GO:0071378 | cellular response to growth hormone stimulus | 2.050990e-3 |
GO:0060579 | ventral spinal cord interneuron fate commitment | 2.124510e-3 |
GO:0050995 | negative regulation of lipid catabolic process | 2.180635e-3 |
GO:0009798 | axis specification | 2.184488e-3 |
GO:0046323 | glucose import | 2.202815e-3 |
GO:0071294 | cellular response to zinc ion | 2.203082e-3 |
GO:0070078 | histone H3-R2 demethylation | 2.227233e-3 |
GO:0070079 | histone H4-R3 demethylation | 2.227233e-3 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 2.227233e-3 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 2.227233e-3 |
GO:0070508 | cholesterol import | 2.266796e-3 |
GO:2000195 | negative regulation of female gonad development | 2.272827e-3 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 2.306334e-3 |
GO:0060621 | negative regulation of cholesterol import | 2.318381e-3 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 2.318381e-3 |
GO:0021569 | rhombomere 3 development | 2.318381e-3 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 2.353413e-3 |
GO:0035269 | protein O-linked mannosylation | 2.393946e-3 |
GO:0035562 | negative regulation of chromatin binding | 2.393946e-3 |
GO:0017145 | stem cell division | 2.462390e-3 |
GO:0061088 | regulation of sequestering of zinc ion | 2.477776e-3 |
GO:0007497 | posterior midgut development | 2.477776e-3 |
GO:0035645 | enteric smooth muscle cell differentiation | 2.477776e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 2.569283e-3 |
GO:0010824 | regulation of centrosome duplication | 2.575436e-3 |
GO:0016568 | chromatin modification | 2.697353e-3 |
GO:0006600 | creatine metabolic process | 2.702879e-3 |
GO:0060684 | epithelial-mesenchymal cell signaling | 2.717741e-3 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 2.743823e-3 |
GO:0031427 | response to methotrexate | 2.743823e-3 |
GO:0003148 | outflow tract septum morphogenesis | 2.753468e-3 |
GO:0008355 | olfactory learning | 2.872223e-3 |
GO:0030902 | hindbrain development | 2.883581e-3 |
GO:0060911 | cardiac cell fate commitment | 2.914861e-3 |
GO:0009952 | anterior/posterior pattern specification | 2.922639e-3 |
GO:0042363 | fat-soluble vitamin catabolic process | 2.941764e-3 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 3.002713e-3 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 3.002713e-3 |
GO:0070171 | negative regulation of tooth mineralization | 3.002713e-3 |
GO:0018242 | protein O-linked glycosylation via serine | 3.002713e-3 |
GO:0007356 | thorax and anterior abdomen determination | 3.002713e-3 |
GO:0018243 | protein O-linked glycosylation via threonine | 3.002713e-3 |
GO:0051145 | smooth muscle cell differentiation | 3.039330e-3 |
GO:0016926 | protein desumoylation | 3.079299e-3 |
GO:0035886 | vascular smooth muscle cell differentiation | 3.157299e-3 |
GO:0090307 | spindle assembly involved in mitosis | 3.164899e-3 |
GO:0060192 | negative regulation of lipase activity | 3.392447e-3 |
GO:0042941 | D-alanine transport | 3.434324e-3 |
GO:0080164 | regulation of nitric oxide metabolic process | 3.434324e-3 |
GO:0035502 | metanephric ureteric bud development | 3.434324e-3 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 3.434324e-3 |
GO:0007518 | myoblast cell fate determination | 3.434324e-3 |
GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 3.434324e-3 |
GO:0006683 | galactosylceramide catabolic process | 3.434324e-3 |
GO:0001570 | vasculogenesis | 3.437251e-3 |
GO:0021532 | neural tube patterning | 3.449142e-3 |
GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 3.492663e-3 |
GO:0060431 | primary lung bud formation | 3.492663e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 3.498567e-3 |
GO:0035414 | negative regulation of catenin import into nucleus | 3.506636e-3 |
GO:0035024 | negative regulation of Rho protein signal transduction | 3.541530e-3 |
GO:0046639 | negative regulation of alpha-beta T cell differentiation | 3.541530e-3 |
GO:0072355 | histone H3-T3 phosphorylation | 3.544026e-3 |
GO:0032782 | bile acid secretion | 3.544026e-3 |
GO:0003096 | renal sodium ion transport | 3.544026e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 3.544026e-3 |
GO:0018293 | protein-FAD linkage | 3.544026e-3 |
GO:0016569 | covalent chromatin modification | 3.552802e-3 |
GO:0034653 | retinoic acid catabolic process | 3.865782e-3 |
GO:0060913 | cardiac cell fate determination | 3.865782e-3 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 3.922208e-3 |
GO:0010614 | negative regulation of cardiac muscle hypertrophy | 3.934730e-3 |
GO:0048227 | plasma membrane to endosome transport | 3.981819e-3 |
GO:0046604 | positive regulation of mitotic centrosome separation | 3.981819e-3 |
GO:0032532 | regulation of microvillus length | 3.981819e-3 |
GO:0051645 | Golgi localization | 4.003573e-3 |
GO:0022037 | metencephalon development | 4.068395e-3 |
GO:0032691 | negative regulation of interleukin-1 beta production | 4.085830e-3 |
GO:0035229 | positive regulation of glutamate-cysteine ligase activity | 4.223060e-3 |
GO:0010468 | regulation of gene expression | 4.230478e-3 |
GO:0007339 | binding of sperm to zona pellucida | 4.272255e-3 |
GO:0072074 | kidney mesenchyme development | 4.272255e-3 |
GO:0006599 | phosphagen metabolic process | 4.293600e-3 |
GO:0042977 | activation of JAK2 kinase activity | 4.310340e-3 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 4.310340e-3 |
GO:0072513 | positive regulation of secondary heart field cardioblast proliferation | 4.386440e-3 |
GO:0006403 | RNA localization | 4.394546e-3 |
GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis | 4.420762e-3 |
GO:0032328 | alanine transport | 4.438046e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 4.438046e-3 |
GO:0046785 | microtubule polymerization | 4.438046e-3 |
GO:0035372 | protein localization to microtubule | 4.449748e-3 |
GO:0010633 | negative regulation of epithelial cell migration | 4.449748e-3 |
GO:0031129 | inductive cell-cell signaling | 4.563080e-3 |
GO:0042473 | outer ear morphogenesis | 4.574792e-3 |
GO:0010556 | regulation of macromolecule biosynthetic process | 4.738557e-3 |
GO:0035194 | posttranscriptional gene silencing by RNA | 4.738666e-3 |
GO:0043060 | meiotic metaphase I plate congression | 4.935757e-3 |
GO:0042048 | olfactory behavior | 4.935757e-3 |
GO:0060711 | labyrinthine layer development | 5.243402e-3 |
GO:0001839 | neural plate morphogenesis | 5.306767e-3 |
GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | 5.322623e-3 |
GO:0046474 | glycerophospholipid biosynthetic process | 5.337687e-3 |
GO:0065001 | specification of axis polarity | 5.459783e-3 |
GO:0060236 | regulation of mitotic spindle organization | 5.459783e-3 |
GO:0043932 | ossification involved in bone remodeling | 5.459783e-3 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 5.459783e-3 |
GO:0045623 | negative regulation of T-helper cell differentiation | 5.570608e-3 |
GO:0017148 | negative regulation of translation | 5.747903e-3 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 5.819612e-3 |
GO:0071354 | cellular response to interleukin-6 | 5.869246e-3 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 5.892096e-3 |
GO:0015959 | diadenosine polyphosphate metabolic process | 5.950092e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 5.950092e-3 |
GO:0045964 | positive regulation of dopamine metabolic process | 5.950092e-3 |
GO:2000194 | regulation of female gonad development | 6.032331e-3 |
GO:0000281 | cytokinesis after mitosis | 6.032331e-3 |
GO:0048840 | otolith development | 6.131914e-3 |
GO:0019049 | evasion of host defenses by virus | 6.154503e-3 |
GO:0042661 | regulation of mesodermal cell fate specification | 6.232022e-3 |
GO:0033566 | gamma-tubulin complex localization | 6.248090e-3 |
GO:0015881 | creatine transport | 6.248090e-3 |
GO:0010070 | zygote asymmetric cell division | 6.248090e-3 |
GO:0014812 | muscle cell migration | 6.302947e-3 |
GO:0016570 | histone modification | 6.495644e-3 |
GO:0072079 | nephron tubule formation | 6.638455e-3 |
GO:0060019 | radial glial cell differentiation | 6.783832e-3 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 6.873409e-3 |
GO:0015012 | heparan sulfate proteoglycan biosynthetic process | 6.873409e-3 |
GO:0007181 | transforming growth factor beta receptor complex assembly | 6.995844e-3 |
GO:0007089 | traversing start control point of mitotic cell cycle | 6.995844e-3 |
GO:0001823 | mesonephros development | 7.025091e-3 |
GO:0021895 | cerebral cortex neuron differentiation | 7.329167e-3 |
GO:0014826 | vein smooth muscle contraction | 7.500777e-3 |
GO:0000278 | mitotic cell cycle | 7.546414e-3 |
GO:0031954 | positive regulation of protein autophosphorylation | 7.570860e-3 |
GO:0072181 | mesonephric duct formation | 7.732901e-3 |
GO:0033484 | nitric oxide homeostasis | 7.732901e-3 |
GO:0016082 | synaptic vesicle priming | 7.794188e-3 |
GO:0060968 | regulation of gene silencing | 7.856831e-3 |
GO:0061205 | paramesonephric duct development | 8.062495e-3 |
GO:0072050 | S-shaped body morphogenesis | 8.111293e-3 |
GO:0072049 | comma-shaped body morphogenesis | 8.111293e-3 |
GO:0032508 | DNA duplex unwinding | 8.241447e-3 |
GO:0060971 | embryonic heart tube left/right pattern formation | 8.399073e-3 |
GO:0060807 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification | 8.399073e-3 |
GO:0001828 | inner cell mass cellular morphogenesis | 8.399073e-3 |
GO:0003142 | cardiogenic plate morphogenesis | 8.399073e-3 |
GO:0007052 | mitotic spindle organization | 8.429151e-3 |
GO:0033979 | box H/ACA snoRNA metabolic process | 8.450791e-3 |
GO:0018214 | protein carboxylation | 8.450791e-3 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 8.473538e-3 |
GO:0032012 | regulation of ARF protein signal transduction | 8.556084e-3 |
GO:0051900 | regulation of mitochondrial depolarization | 8.689727e-3 |
GO:0048268 | clathrin coat assembly | 9.043488e-3 |
GO:0050658 | RNA transport | 9.130168e-3 |
GO:0021953 | central nervous system neuron differentiation | 9.184992e-3 |
GO:0033119 | negative regulation of RNA splicing | 9.308626e-3 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 9.308626e-3 |
GO:0008361 | regulation of cell size | 9.363196e-3 |
GO:0006284 | base-excision repair | 9.396768e-3 |
GO:0070647 | protein modification by small protein conjugation or removal | 9.472271e-3 |
GO:0060317 | cardiac epithelial to mesenchymal transition | 9.509357e-3 |
GO:0035036 | sperm-egg recognition | 9.680702e-3 |
GO:0001840 | neural plate development | 9.702894e-3 |
GO:0021575 | hindbrain morphogenesis | 9.755870e-3 |
GO:0000724 | double-strand break repair via homologous recombination | 9.809319e-3 |
GO:0090102 | cochlea development | 9.857173e-3 |
GO:0061360 | optic chiasma development | 9.950756e-3 |
GO:2000597 | positive regulation of optic nerve formation | 9.950756e-3 |
GO:0045713 | low-density lipoprotein particle receptor biosynthetic process | 9.950756e-3 |
GO:0021650 | vestibulocochlear nerve formation | 9.950756e-3 |
GO:0021633 | optic nerve structural organization | 9.950756e-3 |
GO:0035799 | ureter maturation | 9.950756e-3 |
GO:0060364 | frontal suture morphogenesis | 9.970559e-3 |
GO:0007076 | mitotic chromosome condensation | 1.000283e-2 |
GO:0033483 | gas homeostasis | 1.000283e-2 |
GO:0072348 | sulfur compound transport | 1.016277e-2 |
GO:0007140 | male meiosis | 1.045266e-2 |
GO:0007379 | segment specification | 1.046305e-2 |
GO:0051351 | positive regulation of ligase activity | 1.052355e-2 |
GO:0090244 | Wnt receptor signaling pathway involved in somitogenesis | 1.060746e-2 |
GO:0021549 | cerebellum development | 1.062318e-2 |
GO:0006595 | polyamine metabolic process | 1.072822e-2 |
GO:0070979 | protein K11-linked ubiquitination | 1.073755e-2 |
GO:0006901 | vesicle coating | 1.074445e-2 |
GO:0061384 | heart trabecular morphogenesis | 1.096873e-2 |
GO:0001660 | fever generation | 1.098898e-2 |
GO:0021508 | floor plate formation | 1.098898e-2 |
GO:0002011 | morphogenesis of an epithelial sheet | 1.102084e-2 |
GO:0003348 | cardiac endothelial cell differentiation | 1.102519e-2 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 1.108099e-2 |
GO:0060421 | positive regulation of heart growth | 1.108099e-2 |
GO:0034241 | positive regulation of macrophage fusion | 1.114547e-2 |
GO:0046986 | negative regulation of hemoglobin biosynthetic process | 1.114547e-2 |
GO:0032383 | regulation of intracellular cholesterol transport | 1.114547e-2 |
GO:0021586 | pons maturation | 1.114547e-2 |
GO:0060347 | heart trabecula formation | 1.114650e-2 |
GO:0048143 | astrocyte activation | 1.139993e-2 |
GO:0072078 | nephron tubule morphogenesis | 1.144609e-2 |
GO:0043524 | negative regulation of neuron apoptosis | 1.148199e-2 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.151548e-2 |
GO:0009059 | macromolecule biosynthetic process | 1.153625e-2 |
GO:2000035 | regulation of stem cell division | 1.161979e-2 |
GO:0031848 | protection from non-homologous end joining at telomere | 1.161979e-2 |
GO:0021759 | globus pallidus development | 1.171062e-2 |
GO:0021571 | rhombomere 5 development | 1.171062e-2 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 1.171062e-2 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 1.179135e-2 |
GO:0061011 | hepatic duct development | 1.187729e-2 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 1.187729e-2 |
GO:0072284 | metanephric S-shaped body morphogenesis | 1.192969e-2 |
GO:0021658 | rhombomere 3 morphogenesis | 1.192969e-2 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 1.192969e-2 |
GO:0021515 | cell differentiation in spinal cord | 1.193002e-2 |
GO:0032392 | DNA geometric change | 1.198509e-2 |
GO:0045628 | regulation of T-helper 2 cell differentiation | 1.198837e-2 |
GO:0042662 | negative regulation of mesodermal cell fate specification | 1.202115e-2 |
GO:0032692 | negative regulation of interleukin-1 production | 1.228549e-2 |
GO:0034377 | plasma lipoprotein particle assembly | 1.249384e-2 |
GO:0021548 | pons development | 1.269859e-2 |
GO:0002719 | negative regulation of cytokine production involved in immune response | 1.269859e-2 |
GO:0046847 | filopodium assembly | 1.272131e-2 |
GO:0009452 | RNA capping | 1.307243e-2 |
GO:0007183 | SMAD protein complex assembly | 1.310253e-2 |
GO:0051276 | chromosome organization | 1.320017e-2 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.351436e-2 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 1.356290e-2 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.360286e-2 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 1.367414e-2 |
GO:0045351 | type I interferon biosynthetic process | 1.375103e-2 |
GO:0014056 | regulation of acetylcholine secretion | 1.375103e-2 |
GO:0070165 | positive regulation of adiponectin secretion | 1.384631e-2 |
GO:0070535 | histone H2A K63-linked ubiquitination | 1.384631e-2 |
GO:0051882 | mitochondrial depolarization | 1.384631e-2 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 1.384631e-2 |
GO:0042443 | phenylethylamine metabolic process | 1.384631e-2 |
GO:0000966 | RNA 5'-end processing | 1.384631e-2 |
GO:0033031 | positive regulation of neutrophil apoptosis | 1.384631e-2 |
GO:0071071 | regulation of phospholipid biosynthetic process | 1.384860e-2 |
GO:0021879 | forebrain neuron differentiation | 1.402964e-2 |
GO:0035849 | nephric duct elongation | 1.418726e-2 |
GO:0035847 | uterine epithelium development | 1.418726e-2 |
GO:0035852 | horizontal cell localization | 1.418726e-2 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 1.418726e-2 |
GO:0035846 | oviduct epithelium development | 1.418726e-2 |
GO:0070370 | cellular heat acclimation | 1.418726e-2 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 1.418726e-2 |
GO:0006348 | chromatin silencing at telomere | 1.418726e-2 |
GO:0000962 | positive regulation of mitochondrial RNA catabolic process | 1.418726e-2 |
GO:0000958 | mitochondrial mRNA catabolic process | 1.418726e-2 |
GO:0000965 | mitochondrial RNA 3'-end processing | 1.418726e-2 |
GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.418726e-2 |
GO:0032077 | positive regulation of deoxyribonuclease activity | 1.418726e-2 |
GO:0035356 | cellular triglyceride homeostasis | 1.418726e-2 |
GO:0001755 | neural crest cell migration | 1.419477e-2 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 1.421405e-2 |
GO:0031914 | negative regulation of synaptic plasticity | 1.421405e-2 |
GO:0060177 | regulation of angiotensin metabolic process | 1.442034e-2 |
GO:0035284 | brain segmentation | 1.442034e-2 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.457525e-2 |
GO:0015693 | magnesium ion transport | 1.499714e-2 |
GO:0014051 | gamma-aminobutyric acid secretion | 1.499714e-2 |
GO:0032006 | regulation of TOR signaling cascade | 1.502949e-2 |
GO:0060375 | regulation of mast cell differentiation | 1.506464e-2 |
GO:0035967 | cellular response to topologically incorrect protein | 1.532495e-2 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 1.538619e-2 |
GO:0021871 | forebrain regionalization | 1.552428e-2 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.556896e-2 |
GO:0021516 | dorsal spinal cord development | 1.565544e-2 |
GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification | 1.566255e-2 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 1.618510e-2 |
GO:0042696 | menarche | 1.618510e-2 |
GO:0039020 | pronephric nephron tubule development | 1.649190e-2 |
GO:0035565 | regulation of pronephros size | 1.649190e-2 |
GO:0021930 | cerebellar granule cell precursor proliferation | 1.649190e-2 |
GO:0032530 | regulation of microvillus organization | 1.659299e-2 |
GO:0034508 | centromere complex assembly | 1.660114e-2 |
GO:0051055 | negative regulation of lipid biosynthetic process | 1.677892e-2 |
GO:2000001 | regulation of DNA damage checkpoint | 1.681864e-2 |
GO:0070368 | positive regulation of hepatocyte differentiation | 1.681864e-2 |
GO:0097152 | mesenchymal cell apoptosis | 1.681864e-2 |
GO:0071104 | response to interleukin-9 | 1.681864e-2 |
GO:0060658 | nipple morphogenesis | 1.683210e-2 |
GO:0033505 | floor plate morphogenesis | 1.683210e-2 |
GO:0045162 | clustering of voltage-gated sodium channels | 1.683285e-2 |
GO:0021562 | vestibulocochlear nerve development | 1.683285e-2 |
GO:0007616 | long-term memory | 1.709925e-2 |
GO:0060572 | morphogenesis of an epithelial bud | 1.719930e-2 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.752443e-2 |
GO:0021869 | forebrain ventricular zone progenitor cell division | 1.752683e-2 |
GO:0097116 | gephyrin clustering | 1.777409e-2 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1.814580e-2 |
GO:0001832 | blastocyst growth | 1.838319e-2 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 1.843599e-2 |
GO:0045599 | negative regulation of fat cell differentiation | 1.843808e-2 |
GO:0009103 | lipopolysaccharide biosynthetic process | 1.857740e-2 |
GO:0042637 | catagen | 1.857740e-2 |
GO:0007621 | negative regulation of female receptivity | 1.857740e-2 |
GO:0000301 | retrograde transport, vesicle recycling within Golgi | 1.871161e-2 |
GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation | 1.881912e-2 |
GO:0000725 | recombinational repair | 1.906460e-2 |
GO:0060485 | mesenchyme development | 1.916170e-2 |
GO:0051297 | centrosome organization | 1.952434e-2 |
GO:0043380 | regulation of memory T cell differentiation | 1.957844e-2 |
GO:0048755 | branching morphogenesis of a nerve | 1.957844e-2 |
GO:0021578 | hindbrain maturation | 1.957844e-2 |
GO:0014741 | negative regulation of muscle hypertrophy | 1.959351e-2 |
GO:0030035 | microspike assembly | 1.963335e-2 |
GO:0072177 | mesonephric duct development | 1.969086e-2 |
GO:0051569 | regulation of histone H3-K4 methylation | 1.969086e-2 |
GO:0001778 | plasma membrane repair | 1.969086e-2 |
GO:0045017 | glycerolipid biosynthetic process | 1.980915e-2 |
GO:0060216 | definitive hemopoiesis | 2.042021e-2 |
GO:0022403 | cell cycle phase | 2.050663e-2 |
GO:0019941 | modification-dependent protein catabolic process | 2.051766e-2 |
GO:0051573 | negative regulation of histone H3-K9 methylation | 2.056415e-2 |
GO:0048496 | maintenance of organ identity | 2.056415e-2 |
GO:0060319 | primitive erythrocyte differentiation | 2.082883e-2 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 2.082883e-2 |
GO:0006999 | nuclear pore organization | 2.100704e-2 |
GO:0021799 | cerebral cortex radially oriented cell migration | 2.110785e-2 |
GO:0060038 | cardiac muscle cell proliferation | 2.147318e-2 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 2.147318e-2 |
GO:0021796 | cerebral cortex regionalization | 2.150706e-2 |
GO:0015747 | urate transport | 2.150706e-2 |
GO:0009890 | negative regulation of biosynthetic process | 2.170158e-2 |
GO:0043632 | modification-dependent macromolecule catabolic process | 2.170956e-2 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 2.185256e-2 |
GO:0000082 | G1/S transition of mitotic cell cycle | 2.211541e-2 |